Scarica l'app Stockscreener
27.53
0.18%
0.05
Maze Therapeutics Inc Borsa (MAZE) Ultime notizie
Maze Therapeutics (NasdaqGM:MAZE) Stock Price - Simply Wall Street
Two trusts sold 31,908 and 2,593 shares under Maze Therapeutics (MAZE) CEO Jason V. Coloma’s trading plan. - Stock Titan
After exercising options, Harold Bernstein sold 16,141 Maze Therapeutics (MAZE) shares. - Stock Titan
An officer plans to sell 16,141 Maze Therapeutics (MAZE) shares on October 1, 2026. - Stock Titan
7,500 shares sold under a trading plan at Maze Therapeutics (MAZE) after an option exercise. - Stock Titan
An officer proposes selling 34,501 shares held by two trusts at Maze Therapeutics (Nasdaq: MAZE). - Stock Titan
Maze Therapeutics (Nasdaq:MAZE)Stock Analysis - Simply Wall Street
Maze Therapeutics Chief Medical Officer Dumps Entire Direct Stake in the Company for $255,000 - The Motley Fool
Maze Therapeutics Chief Medical Officer Dumps Entire Direct Stake in the Company for $255,000 - Yahoo Finance
Maze Therapeutics Chief Medical Officer Dumps Entire Direct Stake in the Company for $255,000 - The Globe and Mail
Maze Therapeutics at Citi summit: early data, bigger tests ahead By Investing.com - Investing.com South Africa
Maze Therapeutics at Citi summit: early data, bigger tests ahead By Investing.com - Investing.com Canada
Maze therapeutics president, R&D & CMO, sells $254,501 in shares By Investing.com - Investing.com Australia
Maze Therapeutics at Wells Fargo conference: pipeline gains pace By Investing.com - Investing.com Nigeria
Maze Therapeutics at Wells Fargo conference: pipeline gains pace By Investing.com - Investing.com South Africa
Maze Therapeutics at Wells Fargo conference: pipeline gains pace By Investing.com - Investing.com India
Maze Therapeutics at Wells Fargo conference: pipeline gains pace By Investing.com - Investing.com Canada
Maze Therapeutics at Wells Fargo conference: pipeline gains pace By Investing.com - Investing.com UK
Maze Therapeutics (MAZE) Institutional Ownership 2026 - MarketBeat
Maze therapeutics president, R&D & CMO, sells $254,501 in shares - Investing.com
Maze therapeutics president, R&D & CMO, sells $254,501 in shares By Investing.com - Investing.com Nigeria
Maze therapeutics president, R&D & CMO, sells $254,501 in shares By Investing.com - Investing.com India
Maze therapeutics president, R&D & CMO, sells $254,501 in shares By Investing.com - Investing.com Canada
Maze therapeutics president, R&D & CMO, sells $254,501 in shares By Investing.com - Investing.com UK
Maze therapeutics president, R&D & CMO, sells $254,501 in shares - Investing.com
Maze Therapeutics (MAZE) R&D chief exits direct stake - Stock Titan
Maze Therapeutics CEO Coloma Jason V Offloads 22,638 Shares at $25.77 to $27.12 Each - Kalkine Media
Don't Ignore The Insider Selling In Maze Therapeutics - simplywall.st
Don't Ignore The Insider Selling In Maze Therapeutics - simplywall.st
MAZE News | MAZE THERAPEUTICS INC (NASDAQ:MAZE) - ChartMill
Maze Therapeutics CSBO Atul Dandekar Sells 6,434 Shares to Cover RSU Tax Withholding - Kalkine Media
Maze Therapeutics (NASDAQ: MAZE) officer lines up new stock sale after recent 10b5-1 trades - stocktitan.net
Maze Therapeutics Chief Executive Officer Sold Shares Worth Over $593K - TradingView
Maze Therapeutics (MAZE) legal chief sells stock for taxes - stocktitan.net
Insider at Maze Therapeutics (MAZE) sells shares to cover taxes - stocktitan.net
Maze Therapeutics (MAZE) CEO sells shares to cover taxes - stocktitan.net
Maze Therapeutics (MAZE) R&D chief sells shares to cover RSU taxes - stocktitan.net
Courtney Phillips Executes 11,000 Zero-Cost Options in Maze Therapeutics (NASDAQ: MAZE) on September 1, 2026 - Kalkine Media
Maze Therapeutics Officer Courtney Phillips Reports RSU Vesting and Stock Settlement - Kalkine Media
Maze Therapeutics CEO Jason V Coloma Reports RSU Vesting and Trust Share Sales in Form 4 Filing - Kalkine Media
RSU vesting gives Maze Therapeutics (MAZE) exec 12,500 shares - stocktitan.net
Maze Therapeutics (MAZE) CEO gets 50K shares, trims stake via trust sales - Stock Titan
Rule-based stock plan leads Maze Therapeutics (MAZE) exec to sell shares and log 20,000 RSUs - stocktitan.net
Maze Therapeutics (MAZE) legal chief gets 11,000 shares - stocktitan.net
Officer plans to sell up to $623K in Maze Therapeutics (MAZE) stock from vested RSUs - Stock Titan
Maze Therapeutics to Participate in Three Upcoming Investor Conferences - markets.businessinsider.com
Maze Therapeutics to Participate in Three Upcoming Investor Conferences - finance.yahoo.com
Maze Therapeutics (MAZE) executive plans new stock sale after recent trades - Stock Titan
MindMaze Therapeutics to Present at Upcoming Investor and Industry Conferences - finance.yahoo.com
Maze Therapeutics CSBO Dandekar divests $206,823 of common stock - Investing.com India
0.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):